This panel is designed to detect mutations across 15 key genes associated with various cancers: AKT1, BRAF, EGFR, ERBB2(HER2), FOXL2, GNA11, GNAQ, KIT, KRAS, MET, NRAS, PDGFRA, PIK3CA, RET, and TP53. This evidence concerns the gene MET and cancer.